118 related articles for article (PubMed ID: 9360843)
41. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.
Hernandez L; Fest T; Cazorla M; Teruya-Feldstein J; Bosch F; Peinado MA; Piris MA; Montserrat E; Cardesa A; Jaffe ES; Campo E; Raffeld M
Blood; 1996 Apr; 87(8):3351-9. PubMed ID: 8605352
[TBL] [Abstract][Full Text] [Related]
42. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
43. Retinoblastoma gene product and P21 (WAF1, CIP1) protein expression in non Hodgkin's lymphomas: a multivariate survival analysis.
Korkolopoulou PA; Angelopoulou MK; Kontopidou FN; Patsouris EV; Christodoulou PN; Kittas CN; Davaris P; Pangalis GA
Leuk Lymphoma; 2001 Feb; 40(5-6):647-58. PubMed ID: 11426536
[TBL] [Abstract][Full Text] [Related]
44. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y; Zou M; Farid NR; al-Sedairy ST
Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
[TBL] [Abstract][Full Text] [Related]
45. p53 gene status and expression of p53, mdm2, and p21Waf1/Cip1 proteins in colorectal cancer.
Veloso M; Wrba F; Kaserer K; Heinze G; Magalhães A; Herbst F; Teleky B
Virchows Arch; 2000 Sep; 437(3):241-7. PubMed ID: 11037343
[TBL] [Abstract][Full Text] [Related]
46. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
Naumann U; Durka S; Weller M
Oncogene; 1998 Sep; 17(12):1567-75. PubMed ID: 9794234
[TBL] [Abstract][Full Text] [Related]
47. Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma.
Brynes RK; Wilson CS; Kim AB; McCourty A
Mod Pathol; 1997 Nov; 10(11):1120-7. PubMed ID: 9388063
[TBL] [Abstract][Full Text] [Related]
48. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
Rau B; Sturm I; Lage H; Berger S; Schneider U; Hauptmann S; Wust P; Riess H; Schlag PM; Dörken B; Daniel PT
J Clin Oncol; 2003 Sep; 21(18):3391-401. PubMed ID: 12885834
[TBL] [Abstract][Full Text] [Related]
49. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.
Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S
J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083
[TBL] [Abstract][Full Text] [Related]
50. Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry.
Werness BA; Jobe JS; DiCioccio RA; Piver MS
Int J Gynecol Pathol; 1997 Apr; 16(2):149-55. PubMed ID: 9100069
[TBL] [Abstract][Full Text] [Related]
51. p53 protein over-expression and p53 gene abnormalities in HIV-1-related non-Hodgkin's lymphomas.
De Re V; Carbone A; De Vita S; Gloghini A; Maestro R; Gasparotto D; Vukosavljevic T; Boiocchi M
Int J Cancer; 1994 Mar; 56(5):662-7. PubMed ID: 8314342
[TBL] [Abstract][Full Text] [Related]
52. p21WAF1/CIP1 gene DNA sequencing and its expression in human osteosarcoma.
Liao WM; Zhang CL; Li FB; Zeng BF; Zeng YX
Chin Med J (Engl); 2004 Jun; 117(6):936-40. PubMed ID: 15198903
[TBL] [Abstract][Full Text] [Related]
53. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps.
Murakami K; Mitomi H; Yamashita K; Tanabe S; Saigenji K; Okayasu I
Am J Clin Pathol; 2001 Feb; 115(2):224-34. PubMed ID: 11211611
[TBL] [Abstract][Full Text] [Related]
54. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status.
Agarwal S; Mathur M; Shukla NK; Ralhan R
Oral Oncol; 1998 Sep; 34(5):353-60. PubMed ID: 9861340
[TBL] [Abstract][Full Text] [Related]
55. Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell carcinomas.
Ohashi K; Nemoto T; Eishi Y; Matsuno A; Nakamura K; Hirokawa K
Virchows Arch; 1997 May; 430(5):389-95. PubMed ID: 9174629
[TBL] [Abstract][Full Text] [Related]
56. Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas.
Vidal MJ; Loganzo F; de Oliveira AR; Hayward NK; Albino AP
Melanoma Res; 1995 Aug; 5(4):243-50. PubMed ID: 7496159
[TBL] [Abstract][Full Text] [Related]
57. p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis.
Park YN; Chae KJ; Kwon KW; Oh BK; Lee KS; Lee WJ; Park C
Hepatogastroenterology; 2003; 50(53):1292-6. PubMed ID: 14571721
[TBL] [Abstract][Full Text] [Related]
58. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
59. p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status.
Baldus SE; Schneider PM; Mönig SP; Zirbes TK; Fromm S; Meyer W; Glossmann J; Schüler S; Thiele J; Hölscher AH; Dienes HP
Scand J Gastroenterol; 2001 Sep; 36(9):975-80. PubMed ID: 11521990
[TBL] [Abstract][Full Text] [Related]
60. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma.
Rey MJ; Fernández PL; Jares P; Muñoz M; Nadal A; Peiró N; Nayach I; Mallofré C; Muntané J; Campo E; Estapé J; Cardesa A
J Pathol; 1998 Mar; 184(3):265-71. PubMed ID: 9614378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
